XML 21 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Goodwill And Intangible Assets
9 Months Ended
Jul. 30, 2016
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill And Intangible Assets
Goodwill and Intangible Assets
The following table summarizes goodwill activity by reportable segment during the nine months ended July 30, 2016 (in thousands):
 
Storage Area Networking (“SAN”) 
Products
 
IP Networking Products
 
Global Services
 
Total
Balance at October 31, 2015
 
 
 
 
 
 
 
Goodwill
$
176,325

 
$
1,414,634

 
$
155,416

 
$
1,746,375

Accumulated impairment losses

 
(129,214
)
 

 
(129,214
)
 
176,325

 
1,285,420

 
155,416

 
1,617,161

Acquisitions (1)

 
308,456

 
398,936

 
707,392

Tax adjustments (2)
(5
)
 

 

 
(5
)
Translation adjustments

 
(233
)
 

 
(233
)
Balance at July 30, 2016
 
 
 
 
 
 
 
Goodwill
176,320

 
1,722,857

 
554,352

 
2,453,529

Accumulated impairment losses

 
(129,214
)
 

 
(129,214
)
 
$
176,320

 
$
1,593,643

 
$
554,352

 
$
2,324,315


(1) 
The goodwill acquired relates to the acquisitions completed in March 2016 and May 2016. See Note 3, “Acquisitions,” of the Notes to Condensed Consolidated Financial Statements.
(2) 
The goodwill adjustments were primarily a result of tax benefits from the exercise of stock awards of acquired companies.
The Company conducts its goodwill impairment test annually and whenever events occur or facts and circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying amount. Effective on the first day of the fourth fiscal quarter, the Company changed the date of its annual impairment test for goodwill from the first day of the second fiscal quarter to the first day of the fourth fiscal quarter. This change in the annual impairment test date was made to better coincide with the timing of when the Company prepares its annual budget and financial plans as part of its regular long-range planning process. For the annual goodwill impairment test, the Company uses the income approach, the market approach, or a combination thereof to determine each reporting unit’s fair value. The income approach provides an estimate of fair value based on discounted expected future cash flows (“DCF”). The market approach provides an estimate of fair value by applying various observable market-based multiples to the reporting unit’s operating results and then applying an appropriate control premium. For the initial fiscal year 2016 annual goodwill impairment test, the Company used a combination of these approaches to estimate each reporting unit’s fair value. At the time that the initial fiscal year 2016 annual goodwill impairment test was performed, the Company believed that the income approach and the market approach were equally representative of a reporting unit’s fair value.
Determining the fair value of a reporting unit requires judgment and involves the use of significant estimates and assumptions. The Company based its fair value estimates on assumptions it believes to be reasonable but are inherently uncertain. Estimates and assumptions with respect to the determination of the fair value of its reporting units using the income approach include, among other inputs:
The Company’s operating forecasts;
The Company’s forecasted revenue growth rates; and
Risk-commensurate discount rates and costs of capital.
The Company’s estimates of revenues and costs are based on historical data, various internal estimates, and a variety of external sources, and are developed as part of the Company’s regular long-range planning process. The control premium used in market or combined approaches was determined by considering control premiums offered as part of the acquisitions where acquired companies were comparable with the Company’s reporting units.
Based on the results of the initial annual goodwill impairment analysis performed during the second fiscal quarter of 2016, the Company determined that no impairment needed to be recorded. As of July 30, 2016, no new events had occurred nor had any facts or circumstances changed since the annual goodwill impairment analysis performed during the second quarter of fiscal year 2016 that indicated that the fair values of the reporting units may be less than their current carrying amounts.
Intangible assets other than goodwill are amortized on a straight-line basis over the following estimated remaining useful lives, unless the Company has determined these lives to be indefinite. The Company did not incur costs to renew or extend the term of any acquired finite-lived intangible assets during the nine months ended July 30, 2016.
The following tables present details of the Company’s intangible assets, excluding goodwill (in thousands, except for weighted-average remaining useful life):
 
July 30, 2016
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Net
Carrying
Value
 
Weighted-
Average
Remaining
Useful Life
(In years)
Finite-lived intangible assets:
 
 
 
 
 
 
 
Trade names
$
45,090

 
$
1,105

 
$
43,985

 
14.71
Core/developed technology (1) (2)
254,290

 
23,834

 
230,456

 
5.67
Patent portfolio license (3)
7,750

 
1,669

 
6,081

 
17.00
Customer relationships
141,110

 
8,805

 
132,305

 
6.52
Non-compete agreements
1,050

 
904

 
146

 
0.46
Patents with broader applications
1,040

 
92

 
948

 
13.63
Total finite-lived intangible assets
450,330

 
36,409

 
413,921

 
6.72
Indefinite-lived intangible assets, excluding goodwill:
 
 
 
 
 
 
 
IPR&D (1)
21,000

 

 
21,000

 
 
Total indefinite-lived intangible assets, excluding goodwill
21,000

 

 
21,000

 
 
Total intangible assets, excluding goodwill
$
471,330

 
$
36,409

 
$
434,921

 
 
 
 
 
 
 
 
 
 
 
October 31, 2015
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Net
Carrying
Value
 
Weighted-
Average
Remaining
Useful Life
(In years)
Finite-lived intangible assets:
 
 
 
 
 
 
 
Trade names
$
1,090

 
$
415

 
$
675

 
4.36
Core/developed technology
40,530

 
9,605

 
30,925

 
3.49
Patent portfolio license (3)
7,750

 
849


6,901

 
17.74
Customer relationships
23,110

 
2,484

 
20,626

 
7.18
Non-compete agreements
1,050

 
664

 
386

 
1.17
Patents with broader applications
1,040

 
40

 
1,000

 
14.38
Total finite-lived intangible assets
74,570

 
14,057

 
60,513

 
6.55
Indefinite-lived intangible assets, excluding goodwill:
 
 
 
 
 
 
 
IPR&D (1)
15,110

 

 
15,110

 
 
Total indefinite-lived intangible assets, excluding goodwill
15,110

 

 
15,110

 
 
Total intangible assets, excluding goodwill
$
89,680

 
$
14,057

 
$
75,623

 
 

(1) 
Acquired IPR&D are intangible assets accounted for as indefinite-lived assets until the completion or abandonment of the associated research and development efforts. If the research and development efforts associated with the IPR&D are successfully completed, then the IPR&D intangible assets will be amortized over the estimated useful lives to be determined as of the date the efforts are completed. During the three months ended July 30, 2016, the Company acquired $23.0 million in IPR&D intangible assets in connection with the acquisition of Ruckus. The research and development efforts associated with these IPR&D intangible assets are expected to be completed in fiscal years 2016 and 2017. During the nine months ended July 30, 2016, research and development efforts were completed on $17.1 million of the IPR&D intangible assets, and the completed IPR&D intangible assets are being amortized as core/developed technology over the estimated useful lives of five to seven years.
(2) 
During the nine months ended July 30, 2016$1.0 million of finite-lived intangible assets became fully amortized and, therefore, were removed from the balance sheet.
(3) 
The patent portfolio license was assigned an estimated useful life that reflects the Company’s consumption of the expected defensive benefits related to this license to certain patents. The method of amortization for the patent portfolio license reflects the Company’s estimate of the pattern in which these expected defensive benefits will be used by the Company and is primarily based on the mix of expiration patterns of the individual patents included in the license.
The Company conducts the IPR&D impairment test annually and whenever events occur or facts and circumstances indicate that it is more likely than not that the IPR&D is impaired. Effective on the first day of the fourth fiscal quarter, the Company changed the date of its annual impairment test for IPR&D from the first day of the second fiscal quarter to the first day of the fourth fiscal quarter. This change in the annual impairment test date was made to better coincide with the timing of when the Company prepares its annual budget and financial plans as part of its regular long-range planning process. For the annual IPR&D impairment test, the Company elects the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of the IPR&D assets is less than the carrying amount. If, after assessing the totality of events and circumstances, the Company determines that it is more likely than not that the fair value of the IPR&D assets is less than the carrying amount, then the Company conducts a quantitative analysis to determine the fair value of the IPR&D assets. If the carrying amount of the IPR&D assets exceeds the fair value, then the Company recognizes an impairment loss equal to the difference.
The Company has not identified any changes in circumstances requiring an interim IPR&D impairment test for the nine months ended July 30, 2016, and therefore, the Company determined that no impairment needed to be recorded.
The amortization of finite-lived intangible assets is included in the following line items of the Company’s Condensed Consolidated Statements of Income as follows (in thousands):
 
Three Months Ended
 
Nine Months Ended
 
July 30, 2016
 
August 1, 2015
 
July 30, 2016
 
August 1, 2015
Cost of revenues
$
8,922

 
$
2,549

 
$
15,269

 
$
5,043

General and administrative (1)
271


889

 
821

 
1,654

Amortization of intangible assets
5,498

 
280

 
7,302

 
570

Total
$
14,691

 
$
3,718

 
$
23,392

 
$
7,267


(1) 
The amortization is related to the $7.8 million of perpetual, non-exclusive license to certain patents purchased during the fiscal year ended October 31, 2015.
The following table presents the estimated future amortization of finite-lived intangible assets as of July 30, 2016 (in thousands):
Fiscal Year
 
Estimated
Future
Amortization
2016 (remaining three months)
 
$
18,998

2017
 
72,063

2018
 
63,562

2019
 
60,039

2020
 
59,082

Thereafter
 
140,177

Total
 
$
413,921